Genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma
A study led by Xiujun Cai (Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine) screened the whole genome of hepatocellular carcinoma cells (HepG2) through CRISPR / cas9 system ...
Apr 19, 2022
0
2